$CPRX Recent News U.S. stocks limp into Octobe
Post# of 94145
Posted On: 10/01/2014 12:28:47 PM
$CPRX Recent News
U.S. stocks limp into October 4:25 p.m. Sept. 30, 2014 - Anora Mahmudova
Ebay surges on PayPal spinoff; Ford faces challenges 12:05 p.m. Sept. 30, 2014 - Sue Chang
Ford falls on Europe woes; Cintas, Synnex up on earnings 6:58 p.m. Sept. 29, 2014 - Wallace Witkowski
Catalyst Pharma shares up 17% after drug trial results 4:50 p.m. Sept. 29, 2014 - Wallace Witkowski
Catalyst Pharma cocaine-addiction drug fails study 1:43 p.m. Nov. 8, 2012 - MarketWatch.com
Friday's biggest gaining and declining stocks 4:28 p.m. July 9, 2010 - MarketWatch
Catalyst Pharma stock jumps on patent grant 10:44 a.m. July 9, 2010 - Russ Britt
Friday's biggest gaining and declining stocks 6:57 p.m. May 29, 2009 - MarketWatch
Catalyst study didn't meet primary endpoint 6:36 a.m. May 29, 2009 - Simon Kennedy
Catalyst: CPP-109 didn't meet primary endpoint 6:26 a.m. May 29, 2009 - Simon Kennedy
Catalyst Pharma sees positive results from Vigabatrin 7:32 a.m. Dec. 7, 2007 - Simon Kennedy
Catalyst Pharma: Vigabatrin shows positive Phase II results 7:27 a.m. Dec. 7, 2007 - Simon Kennedy
Wednesday's biggest stock gainers and decliners 7:55 p.m. Jan. 31, 2007 - Michael Baron
Catalyst Pharma started at buy at Stifel Nicolaus 7:51 a.m. Jan. 31, 2007 - Tomi Kilgore
Catalyst Pharma IPO debuting Wed. 8:08 a.m. Nov. 8, 2006 - Steve Gelsi
Catalyst Pharma prices IPO of 3.4M shares at $6/shr 8:00 a.m. Nov. 8, 2006 - Thomas Middleton
What Else Is Under The Hood For Catalyst Pharma? 3:29 p.m. Sept. 30, 2014 - 247WallSt.com
Why Catalyst Pharmaceutical Partners (CPRX) Stock Is Spiking Today 3:09 p.m. Sept. 30, 2014 - TheStreet.com
Update: Catalyst Pharmaceuticals Positive Phase III Trial 3:06 p.m. Sept. 30, 2014 - Seeking Alpha
Firdapse successful in Phase 3 trial 8:26 a.m. Sept. 30, 2014 - Seeking Alpha
Catalyst Pharma Closer to Unconscionable Price Hike for Rare-Disease Drug 7:20 a.m. Sept. 30, 2014 - TheStreet.com
Catalyst Pharmaceutical (CPRX) Jumps: Stock Up 9% - Tale of the Tape 8:51 a.m. Sept. 5, 2014 - Zacks.com
Catalyst Pharmaceutical Partners (CPRX) Worth Watching: Stock Up 10.3% - Tale of the Tape 9:46 a.m. Aug. 26, 2014 - Zacks.com
10-Q: CATALYST PHARMACEUTICAL PARTNERS, INC. 7:51 a.m. Aug. 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
Biotech Stock Mailbag: Arrowhead, Catalyst Pharma 8:06 a.m. Aug. 1, 2014 - TheStreet.com
Biotech Stock Mailbag: MannKind, Bluebird, Northwest Bio, More '14 Tradable Biotech Events 9:30 a.m. July 14, 2014 - TheStreet.com
Do The Math: Ram Selvaraju On The Appeal Of Biotechs In Orphan Diseases 8:48 a.m. April 23, 2014 - Seeking Alpha
Catalyst Pharmaceutical Partners Inc. (CPRX) Jumps: Stock Up 8.6% - Tale of the Tape 8:51 a.m. April 4, 2014 - Zacks.com
Catalyst sets secondary offering 10:49 a.m. April 3, 2014 - Seeking Alpha
7 Stock Picks From an Insider Trading Guru 10:05 a.m. April 2, 2014 - Barrons.com
Good News for Catalyst Pharma - Analyst Blog 6:30 p.m. March 26, 2014 - Zacks.com
Catalyst Pharmaceutical Partners (CPRX) in Focus: Stock Moves 6.2% Higher - Tale of the Tape 9:21 a.m. March 21, 2014 - Zacks.com
Narrower-than-Expected Loss at Catalyst Pharma - Analyst Blog 9:20 a.m. March 20, 2014 - Zacks.com
More on Catalyst Q4: Files to raise $100M 8:54 a.m. March 19, 2014 - Seeking Alpha
10-K: CATALYST PHARMACEUTICAL PARTNERS, INC. 6:06 a.m. March 19, 2014 - Edgar Online - (EDG = 10Q, 10K)
Aegis out positive on Catalyst, CytRx after news 2:42 p.m. Jan. 8, 2014 - Seeking Alpha
Biotech Equities Technical Review -- Celldex Therapeutics, Synthetic Biologics, Geron, Catalyst Pharmaceutical Partners, and NPS Pharmaceuticals 9:15 a.m. Sept. 8, 2014 - PR Newswire - PRF
Catalyst Pharmaceuticals Appoints David D. Muth as Executive Vice President, Corporate Development 8:03 a.m. Sept. 4, 2014 - GlobeNewswire
Catalyst Pharmaceutical Partners to Present at Rodman & Renshaw's 16th Annual Global Investment Conference 8:04 a.m. Sept. 3, 2014 - GlobeNewswire
Catalyst Pharmaceutical Partners Initiates Phase 1(b) Safety and Tolerance Study for CPP-115 8:04 a.m. Sept. 2, 2014 - GlobeNewswire
Orphan Diseases Partnering Terms and Agreements 9:10 p.m. Aug. 27, 2014 - PR Newswire - PRF
Catalyst Pharmaceutical Partners Provides Updates on Progress of Phase 3 Firdapse Study in Patients With Lambert-Eaton Myasthenic Syndrome (LEMS) 8:04 a.m. Aug. 11, 2014 - GlobeNewswire
Catalyst Pharmaceutical Partners to Present at the JMP Securities 2014 Healthcare Conference 8:04 a.m. June 19, 2014 - GlobeNewswire
Catalyst Pharmaceutical Partners Set to Join Russell Microcap(R) Index 1:04 p.m. June 18, 2014 - GlobeNewswire
Catalyst Pharmaceutical Partners to Present at the Jefferies 2014 Global Healthcare Conference 8:04 a.m. May 29, 2014 - GlobeNewswire
Top Gainers under Review -- Research on Stratasys, Auxilium Pharma, Catalyst Pharma Partners, and Real Goods Solar 8:40 a.m. May 23, 2014 - PR Newswire - PRF
Catalyst Pharmaceutical Partners Announces First Quarter 2014 Financial Results and Provides Corporate Update 8:04 a.m. May 16, 2014 - GlobeNewswire
The Shuman Law Firm Investigates Catalyst Pharmaceutical Partners, Inc. 7:01 p.m. May 15, 2014 - BusinessWire - BZX
Catalyst Announces Initiation of an Expanded Access Program to Provide Firdapse at No Cost to U.S. Patients with Lambert-Eaton Myasthenic Syndrome 8:04 a.m. April 23, 2014 - BusinessWire - BZX
Prana Biotechnology Stock Hits New Low 10:47 a.m. April 16, 2014 - ACCESSWIRE
Catalyst Pharmaceutical Partners, Inc. Announces Closing of Previously Announced Public Offering 10:32 a.m. April 8, 2014 - GlobeNewswire
Pandora Media March Active Listener Hours Up 14% in March; eBay Looking to Grow Annual Revenue to $21B by 2015 12:21 a.m. April 4, 2014 - ACCESSWIRE
Catalyst Pharmaceutical Partners, Inc. Prices Public Offering of Common Stock 9:01 a.m. April 3, 2014 - GlobeNewswire
Catalyst Pharmaceutical Partners, Inc. Announces Commencement of Public Offering of Common Stock 4:06 p.m. April 2, 2014 - GlobeNewswire
Catalyst Announces Completion of Enrollment in Pivotal Phase 3 Trial of Firdapse(TM) in Patients With Lambert-Eaton Myasthenic Syndrome 9:26 a.m. April 1, 2014 - GlobeNewswire
Catalyst Pharmaceutical Partners Expands Executive Leadership Team to Support the Commercialization of Firdapse(TM) 8:03 a.m. March 28, 2014 - GlobeNewswire
U.S. stocks limp into October 4:25 p.m. Sept. 30, 2014 - Anora Mahmudova
Ebay surges on PayPal spinoff; Ford faces challenges 12:05 p.m. Sept. 30, 2014 - Sue Chang
Ford falls on Europe woes; Cintas, Synnex up on earnings 6:58 p.m. Sept. 29, 2014 - Wallace Witkowski
Catalyst Pharma shares up 17% after drug trial results 4:50 p.m. Sept. 29, 2014 - Wallace Witkowski
Catalyst Pharma cocaine-addiction drug fails study 1:43 p.m. Nov. 8, 2012 - MarketWatch.com
Friday's biggest gaining and declining stocks 4:28 p.m. July 9, 2010 - MarketWatch
Catalyst Pharma stock jumps on patent grant 10:44 a.m. July 9, 2010 - Russ Britt
Friday's biggest gaining and declining stocks 6:57 p.m. May 29, 2009 - MarketWatch
Catalyst study didn't meet primary endpoint 6:36 a.m. May 29, 2009 - Simon Kennedy
Catalyst: CPP-109 didn't meet primary endpoint 6:26 a.m. May 29, 2009 - Simon Kennedy
Catalyst Pharma sees positive results from Vigabatrin 7:32 a.m. Dec. 7, 2007 - Simon Kennedy
Catalyst Pharma: Vigabatrin shows positive Phase II results 7:27 a.m. Dec. 7, 2007 - Simon Kennedy
Wednesday's biggest stock gainers and decliners 7:55 p.m. Jan. 31, 2007 - Michael Baron
Catalyst Pharma started at buy at Stifel Nicolaus 7:51 a.m. Jan. 31, 2007 - Tomi Kilgore
Catalyst Pharma IPO debuting Wed. 8:08 a.m. Nov. 8, 2006 - Steve Gelsi
Catalyst Pharma prices IPO of 3.4M shares at $6/shr 8:00 a.m. Nov. 8, 2006 - Thomas Middleton
What Else Is Under The Hood For Catalyst Pharma? 3:29 p.m. Sept. 30, 2014 - 247WallSt.com
Why Catalyst Pharmaceutical Partners (CPRX) Stock Is Spiking Today 3:09 p.m. Sept. 30, 2014 - TheStreet.com
Update: Catalyst Pharmaceuticals Positive Phase III Trial 3:06 p.m. Sept. 30, 2014 - Seeking Alpha
Firdapse successful in Phase 3 trial 8:26 a.m. Sept. 30, 2014 - Seeking Alpha
Catalyst Pharma Closer to Unconscionable Price Hike for Rare-Disease Drug 7:20 a.m. Sept. 30, 2014 - TheStreet.com
Catalyst Pharmaceutical (CPRX) Jumps: Stock Up 9% - Tale of the Tape 8:51 a.m. Sept. 5, 2014 - Zacks.com
Catalyst Pharmaceutical Partners (CPRX) Worth Watching: Stock Up 10.3% - Tale of the Tape 9:46 a.m. Aug. 26, 2014 - Zacks.com
10-Q: CATALYST PHARMACEUTICAL PARTNERS, INC. 7:51 a.m. Aug. 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
Biotech Stock Mailbag: Arrowhead, Catalyst Pharma 8:06 a.m. Aug. 1, 2014 - TheStreet.com
Biotech Stock Mailbag: MannKind, Bluebird, Northwest Bio, More '14 Tradable Biotech Events 9:30 a.m. July 14, 2014 - TheStreet.com
Do The Math: Ram Selvaraju On The Appeal Of Biotechs In Orphan Diseases 8:48 a.m. April 23, 2014 - Seeking Alpha
Catalyst Pharmaceutical Partners Inc. (CPRX) Jumps: Stock Up 8.6% - Tale of the Tape 8:51 a.m. April 4, 2014 - Zacks.com
Catalyst sets secondary offering 10:49 a.m. April 3, 2014 - Seeking Alpha
7 Stock Picks From an Insider Trading Guru 10:05 a.m. April 2, 2014 - Barrons.com
Good News for Catalyst Pharma - Analyst Blog 6:30 p.m. March 26, 2014 - Zacks.com
Catalyst Pharmaceutical Partners (CPRX) in Focus: Stock Moves 6.2% Higher - Tale of the Tape 9:21 a.m. March 21, 2014 - Zacks.com
Narrower-than-Expected Loss at Catalyst Pharma - Analyst Blog 9:20 a.m. March 20, 2014 - Zacks.com
More on Catalyst Q4: Files to raise $100M 8:54 a.m. March 19, 2014 - Seeking Alpha
10-K: CATALYST PHARMACEUTICAL PARTNERS, INC. 6:06 a.m. March 19, 2014 - Edgar Online - (EDG = 10Q, 10K)
Aegis out positive on Catalyst, CytRx after news 2:42 p.m. Jan. 8, 2014 - Seeking Alpha
Biotech Equities Technical Review -- Celldex Therapeutics, Synthetic Biologics, Geron, Catalyst Pharmaceutical Partners, and NPS Pharmaceuticals 9:15 a.m. Sept. 8, 2014 - PR Newswire - PRF
Catalyst Pharmaceuticals Appoints David D. Muth as Executive Vice President, Corporate Development 8:03 a.m. Sept. 4, 2014 - GlobeNewswire
Catalyst Pharmaceutical Partners to Present at Rodman & Renshaw's 16th Annual Global Investment Conference 8:04 a.m. Sept. 3, 2014 - GlobeNewswire
Catalyst Pharmaceutical Partners Initiates Phase 1(b) Safety and Tolerance Study for CPP-115 8:04 a.m. Sept. 2, 2014 - GlobeNewswire
Orphan Diseases Partnering Terms and Agreements 9:10 p.m. Aug. 27, 2014 - PR Newswire - PRF
Catalyst Pharmaceutical Partners Provides Updates on Progress of Phase 3 Firdapse Study in Patients With Lambert-Eaton Myasthenic Syndrome (LEMS) 8:04 a.m. Aug. 11, 2014 - GlobeNewswire
Catalyst Pharmaceutical Partners to Present at the JMP Securities 2014 Healthcare Conference 8:04 a.m. June 19, 2014 - GlobeNewswire
Catalyst Pharmaceutical Partners Set to Join Russell Microcap(R) Index 1:04 p.m. June 18, 2014 - GlobeNewswire
Catalyst Pharmaceutical Partners to Present at the Jefferies 2014 Global Healthcare Conference 8:04 a.m. May 29, 2014 - GlobeNewswire
Top Gainers under Review -- Research on Stratasys, Auxilium Pharma, Catalyst Pharma Partners, and Real Goods Solar 8:40 a.m. May 23, 2014 - PR Newswire - PRF
Catalyst Pharmaceutical Partners Announces First Quarter 2014 Financial Results and Provides Corporate Update 8:04 a.m. May 16, 2014 - GlobeNewswire
The Shuman Law Firm Investigates Catalyst Pharmaceutical Partners, Inc. 7:01 p.m. May 15, 2014 - BusinessWire - BZX
Catalyst Announces Initiation of an Expanded Access Program to Provide Firdapse at No Cost to U.S. Patients with Lambert-Eaton Myasthenic Syndrome 8:04 a.m. April 23, 2014 - BusinessWire - BZX
Prana Biotechnology Stock Hits New Low 10:47 a.m. April 16, 2014 - ACCESSWIRE
Catalyst Pharmaceutical Partners, Inc. Announces Closing of Previously Announced Public Offering 10:32 a.m. April 8, 2014 - GlobeNewswire
Pandora Media March Active Listener Hours Up 14% in March; eBay Looking to Grow Annual Revenue to $21B by 2015 12:21 a.m. April 4, 2014 - ACCESSWIRE
Catalyst Pharmaceutical Partners, Inc. Prices Public Offering of Common Stock 9:01 a.m. April 3, 2014 - GlobeNewswire
Catalyst Pharmaceutical Partners, Inc. Announces Commencement of Public Offering of Common Stock 4:06 p.m. April 2, 2014 - GlobeNewswire
Catalyst Announces Completion of Enrollment in Pivotal Phase 3 Trial of Firdapse(TM) in Patients With Lambert-Eaton Myasthenic Syndrome 9:26 a.m. April 1, 2014 - GlobeNewswire
Catalyst Pharmaceutical Partners Expands Executive Leadership Team to Support the Commercialization of Firdapse(TM) 8:03 a.m. March 28, 2014 - GlobeNewswire
(0)
(0)Scroll down for more posts ▼